Diligence memo · auto-generated · as of July 2, 2026

CleanCore Solutions, Inc.

CleanCore Solutions, Inc. looks fair against its niche peers and is active on financing cadence.

SourceRaising on rhythm with a 777.8× step-up on the last round — momentum worth tracking before it's priced in.

Businessfiled

CleanCore Solutions, Inc. operates in Other, based in OMAHA.

Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

CleanCore Solutions, Inc. has raised $177M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).

Largest single filing: $175M on 2025-09-05.

Most recent recorded round closed around 2025-09-05.

Valuation (modeled)modeled

Provath models CleanCore Solutions, Inc. at approximately $1.4B (range $992M–$1.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.47× the median modeled value of Series D+ Other companies in 2025–2027 (50 peers) — value vs value, same stage and era. Within the normal band (147% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 18 months.

Last raise 10 mo ago; this sector typically re-raises about every 11 months.

Raising on or ahead of the sector's normal rhythm.

The last round stepped up 777.8× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 98% of Other peers (25015 compared).

Modeled value ranks above 98% of those peers.

Closest niche peers: AP Adhesives Acquisitions, Inc., INNOVATE Corp., Curaleaf Holdings, Inc., Phantom Parent, LP, Impulse Space, Inc..

Peoplefiled

11 named people on file across officers, directors and signatories.

Risks & flagsmixed

Broad sector classification weakens peer comparison.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.